Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Is ARWR A Good Stock To Buy Right Now?’

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Is Arrowhead Pharmaceuticals Inc (ARWR)’s Recently Published U.S. Patent Application A Blockbuster?

– U.S. Patent and Trademark Office publishes Arrowhead’s latest patent application on αvβ6 integrin ligands. – αvβ6 integrin ligands......(read more)
gene, dna, organism, microarray, health, green, life, human genome, biotechnology, genetic diseases, disease, molecular biology, modern medical, micro structure,

Arrowhead Pharmaceuticals Inc (ARWR): Any Good Hearted Billionaires Out There (Willing To Pick Up Where Arrowhead Left Off)?

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) just shocked markets with the announcement that it would be discontinuing its lead development programs. The......(read more)
biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Today’s Movers And Shakers In Biotech: Arrowhead Pharmaceuticals Inc (ARWR) And Kite Pharma Inc (KITE)

We’re closing in on the end of the week, and it’s time to take a look at which of the companies in the biotech space have moved the most, and what......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Arrowhead Pharmaceuticals Inc. (ARWR), Spring Bank Pharmaceuticals, Inc. (SBPH) Collaborate On HBV

Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) and Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) have recently entered into an agreement for a clinical......(read more)